Accolade Inc (ACCD)
9.345
+0.12
(+1.36%)
USD |
NASDAQ |
Apr 23, 16:00
9.345
0.00 (0.00%)
After-Hours: 17:10
Accolade Cash from Investing (TTM): -12.79M for Nov. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| November 30, 2023 | -12.79M |
| August 31, 2023 | -10.99M |
| May 31, 2023 | -9.333M |
| February 28, 2023 | -7.228M |
| November 30, 2022 | -5.347M |
| August 31, 2022 | -2.715M |
| May 31, 2022 | 63.83M |
| February 28, 2022 | -263.61M |
| Date | Value |
|---|---|
| November 30, 2021 | -263.57M |
| August 31, 2021 | -264.81M |
| May 31, 2021 | -330.60M |
| February 28, 2021 | -2.423M |
| November 30, 2020 | -2.778M |
| August 31, 2020 | -3.664M |
| May 31, 2020 | -3.95M |
| February 29, 2020 | -3.521M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-330.60M
Minimum
May 2021
63.83M
Maximum
May 2022
-70.22M
Average
-6.288M
Median
Cash from Investing (TTM) Benchmarks
| HealthStream Inc | -56.60M |
| HealthEquity Inc | -46.07M |
| Trxade Health Inc | -0.0407M |
| Simulations Plus Inc | -15.94M |
| Schrodinger Inc | 193.03M |